Indenebart Biosimilar (Monoclonal, IgG1)

CAT: 1543-A138064Size: 100 µLDry Ice: NoHazardous: No

1 / 1

CAT#:1543-A138064Size:100 µL

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Product Name Alternative

PD1; NACP; PARK1; PARK4

UniProt

P37840

Reactivity

Human

Target

SNCA

Clonality

Monoclonal

Isotype

IgG1

Related Products

Catalog	Name
A137752	Bevacizumab biosimiar Biosimilar (Monoclonal, IgG1)
A137758	Magrolimab; IgG1 Biosimilar (Monoclonal, IgG1)
A138716	Magrolimab; IgG1 Biosimilar (Monoclonal, IgG1)
A138653	Temtokibart Biosimilar (Monoclonal, IgG1)
A138642	Enibarcimab Biosimilar (Monoclonal, IgG1)
A138637	Anselamimab Biosimilar (Monoclonal, IgG1)
A138621	Vopikitug Biosimilar (Monoclonal, IgG1)
A138595	Tozorakimab Biosimilar (Monoclonal, IgG1)
A138592	Tomuzotuximab Biosimilar (Monoclonal, IgG1)
A138591	Tizetatug Biosimilar (Monoclonal, IgG1)

Catalog	Name
VEGF19-M	Humanized Monoclonal Anti-Human VEGF protein (Avastin/bevacizumab biosimilar) protein IgG1 (neutralizing)
ICH5603-50mg	Indenebart Biosimilar - Research Grade
MBS1881309-01	Anti-SNCA (indenebart biosimilar) mAb
MBS1881310-01	Biotinylated Anti-SNCA (indenebart biosimilar) mAb
GTR18695716-01	Indenebart Human Monoclonal Antibody
MBS1881311-01	PE-conjugated Anti-SNCA (indenebart biosimilar) mAb
PX-TA2167-01	Indenebart Biosimilar - Anti-Alpha-synuclein mAb - Research Grade
GTR18622450-01	IgG1 / Kappa Isotype Control (MMAE Biosimilar)
TA421248	Anti-CD47 (magrolimab biosimilar;IgG1) mAb
E33B100050	Anti-CD47 (magrolimab biosimilar; IgG1) mAb